Table 1 Demographic and clinical features of enrolled EGID patients
Overall | EoE | Non-esophageal EGIDs | |
|---|---|---|---|
EGID patients, n (%) | 60 (100) | 39 (65) | 21 (35) |
Male, n (%) | 42 (70) | 29 (74) | 14 (67) |
Caucasian, n (%) | 53 (88) | 33 (85) | 20 (95) |
Age at diagnosis | |||
≤ 1 year, n (%) | 4 (6.7) | 3 (7.8) | 1 (4.8) |
1–5 years, n (%) | 10 (16.7) | 9 (23) | 1 (4.8) |
6–11 years, n (%) | 25 (41.6) | 14 (35.9) | 11 (52.4) |
≥ 12 years, n (%) | 21 (35) | 13 (33.3) | 8 (38.0) |
Coexisting allergic diseases, n (%) | 38 (63) | 27 (70) | 11 (52) |
Allergic rhinitis, n (%) | 30 (50) | 19 (49) | 11 (52) |
Asthma, n (%) | 12 (20) | 10 (26) | 2 (10) |
Atopic dermatitis, n (%) | 11 (18) | 9 (23) | 2 (10) |
Food allergy, n (%) | 15 (25) | 13 (33) | 2 (10) |
Symptoms | |||
Abdominal pain, n (%) | 32 (53) | 14 (36) | 18 (86) |
Diarrhea, n (%) | 8 (13) | 0 (0) | 8 (38) |
Dysphagia, n (%) | 9 (23) | 9 (23) | 0 (0) |
Failure to thrive, n (%) | 12 (20) | 10 (26) | 2 (10) |
Food impaction, n (%) | 8 (13) | 8 (21) | 0 (0) |
GERD-like symptoms, n (%) | 20 (33) | 20 (51) | 0 (0) |
Nausea and vomiting, n (%) | 15 (25) | 12 (31) | 3 (14) |
Reduced appetite and feeding issues, n (%) | 7 (12) | 7 (18) | 0 (0) |
Weight loss, n (%) | 3 (5) | 0 (0) | 3 (14) |
Endoscopic findings | |||
Edema, n (%) | 19 (32) | 19 (49) | 0 (0) |
Rings, n (%) | 9 (15) | 9 (23) | 0 (0) |
Exudates, n (%) | 6 (10) | 6 (15) | 0 (0) |
Furrows, n (%) | 7 (12) | 7 (18) | 0 (0) |
Stricture, n (%) | 2 (3) | 2 (5) | 0 (0) |
Normal mucosa, n (%) | 11 (18) | 0 (0) | 11 (52) |
Nodular lymphoid hyperplasia, n (%) | 5 (8) | 0 (0) | 5 (24) |
Mucosal inflammation, n (%) | 5 (8) | 0 (0) | 5 (24) |